Lv41
690 积分 2022-03-15 加入
Cellular Ligand–Receptor Perturbations Unravel MEIS2 as a Key Factor for the Aggressive Progression and Prognosis in Stage II/III Colorectal Cancer
1个月前
已完结
A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice
3个月前
已完结
Co-agonist therapeutics come of age for obesity
3个月前
已完结
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
3个月前
已完结
Exploring the regulation of glucagon secretion
3个月前
已完结
Glucagon, from past to present: a century of intensive research and controversies
3个月前
已完结
Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B
3个月前
已完结
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
3个月前
已完结
Cytoskeleton alterations in non-alcoholic fatty liver disease
4个月前
已完结
Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination
5个月前
已完结
皖公网安备34019202002308
